Merck said it is recalling all lots of Liptruzet, its combination of the cholesterol-lowering drugs ezetimibe and atorvastatin, in the U.S.
Packaging defect leads Merck to recall all lots of Liptruzet
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.